Rate My Professor Elizabeth Anderson

Dr. Anderson's research program centers on breast cancer survivorship and late-treatment side effects, encompassing lymphedema risk, cognitive challenges, fatigue, psychosocial needs, self-management challenges, and interventions to enhance long-term quality of life. She has secured significant recognition, including the Doolin Nursing Research Fellow award for 2025-2026, Learning and Expanding Abilities for Professoriate (LEAP) Fellow from 2024-2026, Midwest Nursing Research Society Self-Care Research Implementation & Interest Group Early Career Research Award for 2026 and Dissertation Award for 2022, American Lymphedema Framework Project Postdoctoral Fellow from 2021-2022, and the Order of Military Medical Merit in 2019, alongside multiple U.S. Army commendations. As principal investigator on an NIH National Cancer Institute R03 grant titled "Surviving Breast Cancer: An exploration of breast cancer diagnosis, reported lymphedema symptoms, and lifestyle status in the Nurses’ Health Study Survey" from September 2024 to August 2026, and co-investigator on projects such as the Tri-Service Nursing Research Program grant from 2026-2028, her contributions advance survivorship care. Notable publications include "Older and Black Breast Cancer Survivors at Higher Risk for Negative Respiratory Outcomes Following COVID-19 Infection" (2025, Western Journal of Nursing Research), "Development of a core outcome set for breast cancer-related lymphedema: A Delphi study" (2024, Breast Cancer Research and Treatment), "Complete decongestive therapy phase 1: An expert consensus document" (2024, Medical Oncology), and chapters in "Principles and Practice of Lymphedema Surgery" (2020). Her work fosters international collaborations through the American Lymphedema Framework Project and informs clinical practices via surveys of lymphedema therapists.